MIMS (Malaysia) drug information results matching Celebrex
User Information
NEWS | CME 
 Coronary CT predicts future cardiac events   Linagliptin lowers blood sugar in type 2 diabetics   Chinese women largely unaware of heart disease and stroke risk   Women's heart attacks differ from men's   Conflicting Recommendations for Lipid Screening and Management in Children: The Need for Consensus   Gefitinib improves progression-free survival in NSCLC with EGFR mutations   Community-based lifestyle intervention beneficial in Chinese diabetes, hypertension patients   7th International Symposium on Respiratory Diseases (ISRD)   Ethnicity is a strong indicator of cardiovascular risk   Asian lung cancer vaccine trial resumes after temporary hold   The JUPITER trial: Do the results apply to Asians?   Type 1 Diabetes Mellitus in Children and Adolescents   Researchers in Asia point to better sepsis treatments   Non-HDL Cholesterol: When and how to Treat   Recommendations for the Management of Neuropathic Pain Associated With Peripheral Nerve Entrapment   
MIMS Info PubMed
Results 1-1 of 1 for Celebrex (0 seconds)
Other(s): China  HK  India  Indonesia  Malaysia  Phil  S'pore  Taiwan  Thai  US  Vietnam  ALL  
Display: Brief  Full      Search in: Drug Only  All  
Celebrex cap® [ Pfizer ]  [ Zuellig Pharma ] - celecoxib
Indication: Relief of acute & chronic pain & inflammation of OA & RA. Management of acute pain in adults & treatment of primary dysmenorrhoea. Ankylosing spondylitis.
MIMS Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) 
Image  Interaction  Patient MedInfo  Search PubMed  

 
  
 
China MIMS Online Home Page Hong Kong MIMS Online Home Page India MIMS Online Home Page Indonesia MIMS Online Home Page Malaysia MIMS Online Home Page Philippines MIMS Online Home Page Singapore MIMS Online Home Page Taiwan MIMS Online Home Page Thailand MIMS Online Home Page Vietnam MIMS Online Home Page